JP2502042C - - Google Patents

Info

Publication number

JP2502042C

JP2502042C JP2502042C JP 2502042 C JP2502042 C JP 2502042C JP 2502042 C JP2502042 C JP 2502042C

Authority

JP

Japan

Prior art keywords

dna

sequence

enzyme

nucleic acid

primer

Prior art date

1998-10-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Lifetime

Links

• Espacenet
• Global Dossier
• Discuss

• 229920003013 deoxyribonucleic acid Polymers 0.000 claims description 154
• 102000004190 Enzymes Human genes 0.000 claims description 143
• 108090000790 Enzymes Proteins 0.000 claims description 143
• 230000000694 effects Effects 0.000 claims description 69
• 229920000272 Oligonucleotide Polymers 0.000 claims description 64
• 238000006243 chemical reaction Methods 0.000 claims description 53
• 101700054624 RF1 Proteins 0.000 claims description 29
• 239000001226 triphosphate Substances 0.000 claims description 29
• 101700011961 DPOM Proteins 0.000 claims description 28
• 101710029649 MDV043 Proteins 0.000 claims description 28
• 101700061424 POLB Proteins 0.000 claims description 28
• 241000589596 Thermus Species 0.000 claims description 20
• 229920001405 Coding region Polymers 0.000 claims description 17
• 241000589500 Thermus aquaticus Species 0.000 claims description 14
• 238000004519 manufacturing process Methods 0.000 claims description 13
• 239000005549 deoxyribonucleoside Substances 0.000 claims description 7
• 239000010452 phosphate Substances 0.000 claims description 7
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 7
• 229940098773 Bovine Serum Albumin Drugs 0.000 claims description 6
• 108091003117 Bovine Serum Albumin Proteins 0.000 claims description 6
• 229920000023 polynucleotide Polymers 0.000 claims description 6
• 239000002157 polynucleotide Substances 0.000 claims description 6
• 239000000758 substrate Substances 0.000 claims description 6
• 241000589499 Thermus thermophilus Species 0.000 claims description 3
• 230000001419 dependent Effects 0.000 claims description 3
• 229940092253 Ovalbumin Drugs 0.000 claims description 2
• 108010058846 Ovalbumin Proteins 0.000 claims description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 2
• 241001603151 Philus Species 0.000 claims 1
• 108010065081 Phosphorylase b Proteins 0.000 claims 1
• 150000007523 nucleic acids Chemical group 0.000 description 177
• 108020004707 nucleic acids Proteins 0.000 description 120
• 229940088598 Enzyme Drugs 0.000 description 107
• 230000003321 amplification Effects 0.000 description 102
• 239000000523 sample Substances 0.000 description 101
• 238000003199 nucleic acid amplification method Methods 0.000 description 97
• 239000000047 product Substances 0.000 description 94
• 229920001850 Nucleic acid sequence Polymers 0.000 description 85
• 210000004027 cells Anatomy 0.000 description 72
• UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 67
• 230000000295 complement Effects 0.000 description 67
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 58
• 239000000727 fraction Substances 0.000 description 56
• 239000002773 nucleotide Substances 0.000 description 52
• 108010006785 Taq Polymerase Proteins 0.000 description 51
• 238000009396 hybridization Methods 0.000 description 49
• 239000000203 mixture Substances 0.000 description 46
• 125000003729 nucleotide group Chemical group 0.000 description 39
• 229940110715 ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Drugs 0.000 description 33
• 229940114721 Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM Drugs 0.000 description 33
• 229940093738 Enzymes for ALIMENTARY TRACT AND METABOLISM Drugs 0.000 description 33
• 229940019336 antithrombotic Enzymes Drugs 0.000 description 33
• 229940020899 hematological Enzymes Drugs 0.000 description 33
• 229940083249 peripheral vasodilators Enzymes Drugs 0.000 description 33
• 235000018102 proteins Nutrition 0.000 description 32
• 102000004169 proteins and genes Human genes 0.000 description 32
• 108090000623 proteins and genes Proteins 0.000 description 32
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
• 238000000034 method Methods 0.000 description 28
• FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
• 239000011780 sodium chloride Substances 0.000 description 28
• 230000002194 synthesizing Effects 0.000 description 28
• 238000003786 synthesis reaction Methods 0.000 description 27
• 238000004458 analytical method Methods 0.000 description 26
• 230000015572 biosynthetic process Effects 0.000 description 26
• 239000000243 solution Substances 0.000 description 26
• 238000010438 heat treatment Methods 0.000 description 24
• 238000010367 cloning Methods 0.000 description 23
• 239000012528 membrane Substances 0.000 description 23
• 210000004379 Membranes Anatomy 0.000 description 22
• 108091007521 restriction endonucleases Proteins 0.000 description 22
• 235000011178 triphosphate Nutrition 0.000 description 22
• 238000001514 detection method Methods 0.000 description 21
• KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 20
• -1 nucleotide triphosphates Chemical class 0.000 description 20
• PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
• 108010017826 DNA Polymerase I Proteins 0.000 description 18
• 102000004594 DNA Polymerase I Human genes 0.000 description 18
• LWIHDJKSTIGBAC-UHFFFAOYSA-K Tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 18
• 241000588724 Escherichia coli Species 0.000 description 16
• 230000035772 mutation Effects 0.000 description 16
• 239000011541 reaction mixture Substances 0.000 description 16
• LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 15
• 102100019126 HBB Human genes 0.000 description 15
• 108091005902 Hemoglobin subunit beta Proteins 0.000 description 15
• 230000036425 denaturation Effects 0.000 description 14
• 238000004925 denaturation Methods 0.000 description 14
• 241000894007 species Species 0.000 description 14
• 238000001816 cooling Methods 0.000 description 13
• 150000003839 salts Chemical class 0.000 description 13
• 108010010803 Gelatin Proteins 0.000 description 12
• 238000000137 annealing Methods 0.000 description 12
• 201000010099 disease Diseases 0.000 description 12
• 239000008273 gelatin Substances 0.000 description 12
• 229920000159 gelatin Polymers 0.000 description 12
• 235000019322 gelatine Nutrition 0.000 description 12
• 235000011852 gelatine desserts Nutrition 0.000 description 12
• DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 11
• 239000007983 Tris buffer Substances 0.000 description 11
• 238000010790 dilution Methods 0.000 description 11
• 230000002068 genetic Effects 0.000 description 11
• HAAZLUGHYHWQIW-KVQBGUIXSA-N Deoxyguanosine triphosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 10
• 108010042407 Endonucleases Proteins 0.000 description 10
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 10
• 239000003599 detergent Substances 0.000 description 10
• 238000000502 dialysis Methods 0.000 description 10
• 238000000746 purification Methods 0.000 description 10
• RZCIEJXAILMSQK-JXOAFFINSA-N 5-Methyluridine triphosphate Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 9
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
• HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 9
• SUYVUBYJARFZHO-RRKCRQDMSA-J dATP(4-) Chemical group C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-J 0.000 description 9
• 238000001962 electrophoresis Methods 0.000 description 9
• 235000011187 glycerol Nutrition 0.000 description 9
• 229910000160 potassium phosphate Inorganic materials 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 201000007023 thrombotic thrombocytopenic purpura Diseases 0.000 description 9
• 230000001131 transforming Effects 0.000 description 9
• 235000019798 tripotassium phosphate Nutrition 0.000 description 9
• RGWHQCVHVJXOKC-SHYZEUOFSA-N Deoxycytidine triphosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 8
• 101700008821 EXO Proteins 0.000 description 8
• 101700083023 EXRN Proteins 0.000 description 8
• 229920001213 Polysorbate 20 Polymers 0.000 description 8
• 230000001580 bacterial Effects 0.000 description 8
• 239000001913 cellulose Substances 0.000 description 8
• 229920002678 cellulose Polymers 0.000 description 8
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
• 239000000499 gel Substances 0.000 description 8
• 230000001965 increased Effects 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 244000005700 microbiome Species 0.000 description 8
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
• 238000000926 separation method Methods 0.000 description 8
• 239000006228 supernatant Substances 0.000 description 8
• UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 8
• 229920000160 (ribonucleotides)n+m Polymers 0.000 description 7
• 241000894006 Bacteria Species 0.000 description 7
• 239000003155 DNA primer Substances 0.000 description 7
• 102100005410 LINE-1 retrotransposable element ORF2 protein Human genes 0.000 description 7
• 210000004457 Myocytus nodalis Anatomy 0.000 description 7
• 101700080605 NUC1 Proteins 0.000 description 7
• 208000007056 Sickle Cell Anemia Diseases 0.000 description 7
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
• 108090001123 antibodies Proteins 0.000 description 7
• 102000004965 antibodies Human genes 0.000 description 7
• 238000003776 cleavage reaction Methods 0.000 description 7
• 238000010276 construction Methods 0.000 description 7
• 230000001809 detectable Effects 0.000 description 7
• 230000029087 digestion Effects 0.000 description 7
• 201000009910 diseases by infectious agent Diseases 0.000 description 7
• 239000002480 mineral oil Substances 0.000 description 7
• 235000010446 mineral oil Nutrition 0.000 description 7
• 101700006494 nucA Proteins 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
• ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 6
• 241000283973 Oryctolagus cuniculus Species 0.000 description 6
• 210000002966 Serum Anatomy 0.000 description 6
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• 229960002685 biotin Drugs 0.000 description 6
• 235000020958 biotin Nutrition 0.000 description 6
• 239000011616 biotin Substances 0.000 description 6
• 239000003153 chemical reaction reagent Substances 0.000 description 6
• 238000011109 contamination Methods 0.000 description 6
• 230000000875 corresponding Effects 0.000 description 6
• RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 230000004927 fusion Effects 0.000 description 6
• 238000002955 isolation Methods 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 241001515965 unidentified phage Species 0.000 description 6
• VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dimercaptobutane-2,3-diol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 5
• 229960001701 Chloroform Drugs 0.000 description 5
• 108020004705 Codon Proteins 0.000 description 5
• 229920002676 Complementary DNA Polymers 0.000 description 5
• CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
• 241001646716 Escherichia coli K-12 Species 0.000 description 5
• 241000701959 Escherichia virus Lambda Species 0.000 description 5
• 108090000364 Ligases Proteins 0.000 description 5
• 102000003960 Ligases Human genes 0.000 description 5
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 5
• 238000000246 agarose gel electrophoresis Methods 0.000 description 5
• 150000001413 amino acids Chemical class 0.000 description 5
• 208000005980 beta-Thalassemia Diseases 0.000 description 5
• 238000004166 bioassay Methods 0.000 description 5
• 230000024881 catalytic activity Effects 0.000 description 5
• 238000005119 centrifugation Methods 0.000 description 5
• 150000001875 compounds Chemical class 0.000 description 5
• 201000002406 genetic disease Diseases 0.000 description 5
• 238000002372 labelling Methods 0.000 description 5
• 239000002751 oligonucleotide probe Substances 0.000 description 5
• 230000036961 partial Effects 0.000 description 5
• 235000021317 phosphate Nutrition 0.000 description 5
• 101710004466 rgy Proteins 0.000 description 5
• 101710030364 rgy1 Proteins 0.000 description 5
• 101710030359 rgy2 Proteins 0.000 description 5
• 241000283690 Bos taurus Species 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• 241000725303 Human immunodeficiency virus Species 0.000 description 4
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 4
• 108020004511 Recombinant DNA Proteins 0.000 description 4
• 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 4
• PFNFFQXMRSDOHW-UHFFFAOYSA-N Spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 4
• 241000700605 Viruses Species 0.000 description 4
• WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 239000011543 agarose gel Substances 0.000 description 4
• 235000001014 amino acid Nutrition 0.000 description 4
• 239000007795 chemical reaction product Substances 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 239000000287 crude extract Substances 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl β-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
• 101710030587 ligN Proteins 0.000 description 4
• 101700077585 ligd Proteins 0.000 description 4
• 239000003550 marker Substances 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000006011 modification reaction Methods 0.000 description 4
• 238000002703 mutagenesis Methods 0.000 description 4
• 231100000350 mutagenesis Toxicity 0.000 description 4
• 239000002244 precipitate Substances 0.000 description 4
• 238000001556 precipitation Methods 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 230000002285 radioactive Effects 0.000 description 4
• 230000002829 reduced Effects 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 230000035945 sensitivity Effects 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• 101710036216 ATEG_03556 Proteins 0.000 description 3
• 229960000583 Acetic Acid Drugs 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
• 102000006734 Beta-Globulins Human genes 0.000 description 3
• 108010087504 Beta-Globulins Proteins 0.000 description 3
• 239000003298 DNA probe Substances 0.000 description 3
• 101710034658 DNASE1 Proteins 0.000 description 3
• 102000033147 ERVK-25 Human genes 0.000 description 3
• ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
• 229920001917 Ficoll Polymers 0.000 description 3
• 102100011343 GLB1 Human genes 0.000 description 3
• 230000036499 Half live Effects 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 239000004677 Nylon Substances 0.000 description 3
• 101710003000 ORF1/ORF2 Proteins 0.000 description 3
• 101700030467 Pol Proteins 0.000 description 3
• 229920000978 Start codon Polymers 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
• 235000011130 ammonium sulphate Nutrition 0.000 description 3
• 238000000211 autoradiogram Methods 0.000 description 3
• 108010005774 beta-Galactosidase Proteins 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 230000001351 cycling Effects 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 238000001976 enzyme digestion Methods 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 238000000605 extraction Methods 0.000 description 3
• 238000005194 fractionation Methods 0.000 description 3
• 238000001502 gel electrophoresis Methods 0.000 description 3
• 238000003505 heat denaturation Methods 0.000 description 3
• 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
• 230000001976 improved Effects 0.000 description 3
• 230000002934 lysing Effects 0.000 description 3
• 210000004962 mammalian cells Anatomy 0.000 description 3
• 229920001778 nylon Polymers 0.000 description 3
• 229920003023 plastic Polymers 0.000 description 3
• 239000004033 plastic Substances 0.000 description 3
• 229920002401 polyacrylamide Polymers 0.000 description 3
• 239000008057 potassium phosphate buffer Substances 0.000 description 3
• 239000011535 reaction buffer Substances 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000001105 regulatory Effects 0.000 description 3
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
• 238000003756 stirring Methods 0.000 description 3
• 239000012536 storage buffer Substances 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 210000001519 tissues Anatomy 0.000 description 3
• 101710006356 ACTI Proteins 0.000 description 2
• 210000003165 Abomasum Anatomy 0.000 description 2
• 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
• 239000005695 Ammonium acetate Substances 0.000 description 2
• AVKUERGKIZMTKX-NJBDSQKTSA-N Ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
• 101700046715 CSTI Proteins 0.000 description 2
• 229940041514 Candida albicans extract Drugs 0.000 description 2
• 208000005623 Carcinogenesis Diseases 0.000 description 2
• 210000000349 Chromosomes Anatomy 0.000 description 2
• 101700020566 DEFA4 Proteins 0.000 description 2
• 108020003215 DNA Probes Proteins 0.000 description 2
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
• 102000008422 EC 2.7.1.78 Human genes 0.000 description 2
• 108010021757 EC 2.7.1.78 Proteins 0.000 description 2
• 241001524679 Escherichia virus M13 Species 0.000 description 2
• 210000002196 Fr. B Anatomy 0.000 description 2
• 210000000540 Fraction C Anatomy 0.000 description 2
• 240000007842 Glycine max Species 0.000 description 2
• 235000010469 Glycine max Nutrition 0.000 description 2
• 108010062347 HLA-DQ Antigens Proteins 0.000 description 2
• 108010053491 HLA-DR beta-Chains Proteins 0.000 description 2
• 206010018883 Haemoglobin C disease Diseases 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• 101710006353 IP3R Proteins 0.000 description 2
• 101700035656 ISOTI Proteins 0.000 description 2
• 101700035039 ITI Proteins 0.000 description 2
• 101700052013 ITR2 Proteins 0.000 description 2
• 101700068039 ITRP Proteins 0.000 description 2
• GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 2
• 101700036939 MTI Proteins 0.000 description 2
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
• GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 108020004999 Messenger RNA Proteins 0.000 description 2
• 102000016943 Muramidase Human genes 0.000 description 2
• 108010014251 Muramidase Proteins 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
• 108090000854 Oxidoreductases Proteins 0.000 description 2
• 102000004316 Oxidoreductases Human genes 0.000 description 2
• 108091005771 Peptidases Proteins 0.000 description 2
• 235000014676 Phragmites communis Nutrition 0.000 description 2
• 239000004743 Polypropylene Substances 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 241000589516 Pseudomonas Species 0.000 description 2
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N Psoralen Chemical group C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
• 102000007312 Recombinant Proteins Human genes 0.000 description 2
• 108010033725 Recombinant Proteins Proteins 0.000 description 2
• 229920001914 Ribonucleotide Polymers 0.000 description 2
• 241001000605 Semia Species 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• GEHJYWRUCIMESM-UHFFFAOYSA-L Sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 241000256248 Spodoptera Species 0.000 description 2
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
• CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 2
• 101700062451 TI Proteins 0.000 description 2
• 229960002180 Tetracycline Drugs 0.000 description 2
• OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 2
• 239000004098 Tetracycline Substances 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 238000002835 absorbance Methods 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
• 201000006288 alpha thalassemia Diseases 0.000 description 2
• USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
• 229940043376 ammonium acetate Drugs 0.000 description 2
• 235000019257 ammonium acetate Nutrition 0.000 description 2
• VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
• 239000000908 ammonium hydroxide Substances 0.000 description 2
• 229960000723 ampicillin Drugs 0.000 description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 230000001413 cellular Effects 0.000 description 2
• 239000012141 concentrate Substances 0.000 description 2
• 238000009833 condensation Methods 0.000 description 2
• 230000005494 condensation Effects 0.000 description 2
• 230000037030 denaturation temperature Effects 0.000 description 2
• 238000002298 density-gradient ultracentrifugation Methods 0.000 description 2
• 238000006642 detritylation reaction Methods 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 230000002708 enhancing Effects 0.000 description 2
• 230000002255 enzymatic Effects 0.000 description 2
• 238000001704 evaporation Methods 0.000 description 2
• 102000037240 fusion proteins Human genes 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 230000002414 glycolytic Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 238000003119 immunoblot Methods 0.000 description 2
• 230000000984 immunochemical Effects 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 230000000415 inactivating Effects 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 230000002427 irreversible Effects 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 238000011068 load Methods 0.000 description 2
• 239000004325 lysozyme Substances 0.000 description 2
• 229960000274 lysozyme Drugs 0.000 description 2
• 235000010335 lysozyme Nutrition 0.000 description 2
• 239000011777 magnesium Substances 0.000 description 2
• 159000000003 magnesium salts Chemical class 0.000 description 2
• 229920002106 messenger RNA Polymers 0.000 description 2
• YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 230000001575 pathological Effects 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 230000001402 polyadenylating Effects 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 238000006116 polymerization reaction Methods 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 230000000717 retained Effects 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 239000011435 rock Substances 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
• 239000001632 sodium acetate Substances 0.000 description 2
• 235000017281 sodium acetate Nutrition 0.000 description 2
• 229940063675 spermine Drugs 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• 235000019364 tetracycline Nutrition 0.000 description 2
• WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
• 239000002753 trypsin inhibitor Substances 0.000 description 2
• 239000012137 tryptone Substances 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 210000004885 white matter Anatomy 0.000 description 2
• 239000012138 yeast extract Substances 0.000 description 2
• 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
• VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-Phosphoglyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• ZWDDDMUEPPWHCK-UHFFFAOYSA-N 6-[3-octadec-9-ynoyloxy-2-(1-oxidoethenyloxoniumylidene)propyl]oxoniumylidene-2-(oxidomethyl)-4,5-dioxopyran-3-olate Chemical compound [CH2+]CCCCCCCC#CCCCCCCCC(=O)OCC(=[O+]C([O-])=C)C[O+]=C1OC(C[O-])=C([O-])C(=O)C1=O ZWDDDMUEPPWHCK-UHFFFAOYSA-N 0.000 description 1
• 102100001249 ALB Human genes 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
• 210000004381 Amniotic Fluid Anatomy 0.000 description 1
• 208000007502 Anemia Diseases 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 240000008371 Bacillus subtilis Species 0.000 description 1
• 229940075615 Bacillus subtilis Drugs 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 210000004369 Blood Anatomy 0.000 description 1
• 241000908115 Bolivar Species 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 241000701922 Bovine parvovirus Species 0.000 description 1
• RFUDNHOJZJOFTG-UHFFFAOYSA-N CCOP(N)[O-] Chemical compound CCOP(N)[O-] RFUDNHOJZJOFTG-UHFFFAOYSA-N 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-L CHEBI:8154 Chemical class [O-]P([O-])=O ABLZXFCXXLZCGV-UHFFFAOYSA-L 0.000 description 1
• 108090000209 Carbonic Anhydrases Proteins 0.000 description 1
• 102000003846 Carbonic Anhydrases Human genes 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 210000002421 Cell Wall Anatomy 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 229960005091 Chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N Chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 241000511343 Chondrostoma nasus Species 0.000 description 1
• 210000001136 Chorion Anatomy 0.000 description 1
• 210000000078 Claw Anatomy 0.000 description 1
• GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 108009000097 DNA Replication Proteins 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 102000016928 DNA-Directed DNA Polymerase Human genes 0.000 description 1
• 108010014303 DNA-Directed DNA Polymerase Proteins 0.000 description 1
• 241000255925 Diptera Species 0.000 description 1
• 102000019622 EC 2.7.1.2 Human genes 0.000 description 1
• 108010021582 EC 2.7.1.2 Proteins 0.000 description 1
• 108010092799 EC 2.7.7.49 Proteins 0.000 description 1
• 102000012288 EC 4.2.1.11 Human genes 0.000 description 1
• 108010022181 EC 4.2.1.11 Proteins 0.000 description 1
• 102000005731 EC 5.3.1.9 Human genes 0.000 description 1
• 108010070600 EC 5.3.1.9 Proteins 0.000 description 1
• 102000004533 Endonucleases Human genes 0.000 description 1
• 210000003743 Erythrocytes Anatomy 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 210000003918 Fraction A Anatomy 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
• 229960002989 Glutamic Acid Drugs 0.000 description 1
• 108091000071 Glycerol Kinase Proteins 0.000 description 1
• 102000002387 Glycerol kinases Human genes 0.000 description 1
• 102100004899 HBG2 Human genes 0.000 description 1
• 108010010378 HLA-DP Antigens Proteins 0.000 description 1
• 102000015789 HLA-DP Antigens Human genes 0.000 description 1
• 102000007513 Hemoglobin A Human genes 0.000 description 1
• 108010085682 Hemoglobin A Proteins 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 229960002897 Heparin Drugs 0.000 description 1
• ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
• 208000006454 Hepatitis Diseases 0.000 description 1
• 206010061205 Hereditary disease Diseases 0.000 description 1
• 108020002022 Hexokinases Proteins 0.000 description 1
• 102000005548 Hexokinases Human genes 0.000 description 1
• 241000701109 Human adenovirus 2 Species 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 108090000745 Immune Sera Proteins 0.000 description 1
• 108060003951 Immunoglobulins Proteins 0.000 description 1
• 102000018358 Immunoglobulins Human genes 0.000 description 1
• 229920002459 Intron Polymers 0.000 description 1
• 108020004391 Introns Proteins 0.000 description 1
• BAUYGSIQEAFULO-UHFFFAOYSA-L Iron(II) sulfate Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
• 102000004195 Isomerases Human genes 0.000 description 1
• 108090000769 Isomerases Proteins 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004317 Lyases Human genes 0.000 description 1
• 108090000856 Lyases Proteins 0.000 description 1
• 229920002521 Macromolecule Polymers 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 241000202997 Methanothermus Species 0.000 description 1
• 241001024304 Mino Species 0.000 description 1
• 229920000460 Mitochondrial DNA Polymers 0.000 description 1
• 108020005196 Mitochondrial DNA Proteins 0.000 description 1
• 102100001119 NRAS Human genes 0.000 description 1
• 101710033916 NRAS Proteins 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• SNICXCGAKADSCV-JTQLQIEISA-N Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
• 229960002715 Nicotine Drugs 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 210000004940 Nucleus Anatomy 0.000 description 1
• 240000001439 Opuntia Species 0.000 description 1
• 210000003463 Organelles Anatomy 0.000 description 1
• 210000001672 Ovary Anatomy 0.000 description 1
• 101710042135 PPi-PFK Proteins 0.000 description 1
• 229950009506 Penicillinase Drugs 0.000 description 1
• 108010087702 Penicillinase Proteins 0.000 description 1
• 102000030951 Phosphotransferases Human genes 0.000 description 1
• 108091000081 Phosphotransferases Proteins 0.000 description 1
• 229940023488 Pill Drugs 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 241000224016 Plasmodium Species 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J Pyrophosphate Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 229940048084 Pyrophosphate Drugs 0.000 description 1
• 229940076788 Pyruvate Drugs 0.000 description 1
• 210000003324 RBC Anatomy 0.000 description 1
• 102000001218 Rec A Recombinases Human genes 0.000 description 1
• 108010055016 Rec A Recombinases Proteins 0.000 description 1
• 229960002477 Riboflavin Drugs 0.000 description 1
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
• AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 241000235070 Saccharomyces Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 229920005654 Sephadex Polymers 0.000 description 1
• 239000012507 Sephadex™ Substances 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 229920001533 Single-stranded nucleotide Polymers 0.000 description 1
• JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
• 241000003768 Sphingomonas aquatica Species 0.000 description 1
• 239000008051 TBE buffer Substances 0.000 description 1
• JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
• 210000001541 Thymus Gland Anatomy 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 102000005924 Triose-phosphate isomerases Human genes 0.000 description 1
• 108020003073 Triose-phosphate isomerases Proteins 0.000 description 1
• 239000007984 Tris EDTA buffer Substances 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 206010068760 Ulcers Diseases 0.000 description 1
• 101700035783 YM10 Proteins 0.000 description 1
• 241001080519 Zera Species 0.000 description 1
• GBXZONVFWYCRPT-JGWLITMVSA-N [(2R,3S,4R,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] dihydrogen phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)OP(O)(O)=O GBXZONVFWYCRPT-JGWLITMVSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 229940024142 alpha 1-Antitrypsin Drugs 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 230000000890 antigenic Effects 0.000 description 1
• 239000012062 aqueous buffer Substances 0.000 description 1
• 239000012223 aqueous fraction Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
• QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
• 230000003115 biocidal Effects 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 239000000337 buffer salt Substances 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 238000005266 casting Methods 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 239000004020 conductor Substances 0.000 description 1
• 229920000407 conserved sequence Polymers 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000010192 crystallographic characterization Methods 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000004059 degradation Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 238000011033 desalting Methods 0.000 description 1
• 230000000368 destabilizing Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• ROSDSFDQCJNGOL-UHFFFAOYSA-N dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 229940079593 drugs Drugs 0.000 description 1
• 238000004043 dyeing Methods 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 150000002191 fatty alcohols Chemical class 0.000 description 1
• 239000011790 ferrous sulphate Substances 0.000 description 1
• 235000003891 ferrous sulphate Nutrition 0.000 description 1
• 230000001605 fetal Effects 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 108010038853 gamma-Globins Proteins 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 238000007654 immersion Methods 0.000 description 1
• 230000003100 immobilizing Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 229910052738 indium Inorganic materials 0.000 description 1
• 230000002458 infectious Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000000968 intestinal Effects 0.000 description 1
• 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 230000003902 lesions Effects 0.000 description 1
• 230000000670 limiting Effects 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 238000002715 modification method Methods 0.000 description 1
• QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 229930015196 nicotine Natural products 0.000 description 1
• 150000002825 nitriles Chemical class 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 231100000989 no adverse effect Toxicity 0.000 description 1
• 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 108010058731 nopaline synthase Proteins 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
• 244000045947 parasites Species 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000001717 pathogenic Effects 0.000 description 1
• 244000052769 pathogens Species 0.000 description 1
• 229910000498 pewter Inorganic materials 0.000 description 1
• 239000010957 pewter Substances 0.000 description 1
• 101710036149 pfk-1.2 Proteins 0.000 description 1
• 101700087004 pfkA1 Proteins 0.000 description 1
• 101700035696 pfkB Proteins 0.000 description 1
• 229940080469 phosphocellulose Drugs 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000000865 phosphorylative Effects 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 108091008117 polyclonal antibodies Proteins 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 238000011176 pooling Methods 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
• 238000003793 prenatal diagnosis Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000001737 promoting Effects 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 230000002797 proteolythic Effects 0.000 description 1
• LCTONWCANYUPML-UHFFFAOYSA-M pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 238000010791 quenching Methods 0.000 description 1
• 230000000171 quenching Effects 0.000 description 1
• 210000001995 reticulocyte Anatomy 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 235000019192 riboflavin Nutrition 0.000 description 1
• 239000002151 riboflavin Substances 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 239000004576 sand Substances 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 230000035943 smell Effects 0.000 description 1
• 239000003998 snake venom Substances 0.000 description 1
• 239000007974 sodium acetate buffer Substances 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 235000010265 sodium sulphite Nutrition 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000012134 supernatant fraction Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 235000019157 thiamine Nutrition 0.000 description 1
• KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
• 229960003495 thiamine Drugs 0.000 description 1
• 239000011721 thiamine Substances 0.000 description 1
• 239000010409 thin film Substances 0.000 description 1
• 229910052718 tin Inorganic materials 0.000 description 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
• 239000011778 trisodium citrate Substances 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 239000000052 vinegar Substances 0.000 description 1
• 230000003612 virological Effects 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1